Business Description
bioAffinity Technologies is a San Antonio-based company focused on catching lung cancer early, before it becomes harder to treat. Their main product, CyPath Lung, examines a patient's mucus sample to identify cells that suggest the presence of a lung tumor, all without the need for invasive procedures. Founded in 2014, the company combines laboratory services with ongoing research to improve how lung diseases are detected and understood.
